share_log

4: Statement of changes in beneficial ownership of securities-Director Farley Chele Chiavacci

SEC ·  Nov 21, 2024 05:33

Summary by Moomoo AI

Farley Chele Chiavacci, associated with Conduit Pharmaceuticals, completed a purchase of 299,238 shares of common stock on November 18, 2024. The transaction was carried out at a price of $0.0919 per share, resulting in a total investment of approximately $27,489. The acquisition was made directly and increased Chiavacci's total holdings in the company to 351,510 shares. This transaction reflects a significant buy-in by Chiavacci, signaling potential confidence in the future of Conduit Pharmaceuticals.
Farley Chele Chiavacci, associated with Conduit Pharmaceuticals, completed a purchase of 299,238 shares of common stock on November 18, 2024. The transaction was carried out at a price of $0.0919 per share, resulting in a total investment of approximately $27,489. The acquisition was made directly and increased Chiavacci's total holdings in the company to 351,510 shares. This transaction reflects a significant buy-in by Chiavacci, signaling potential confidence in the future of Conduit Pharmaceuticals.
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more